IL1B and gastric cancer: Additionally, IL-1β is the strongest inhibitor of gastric acid found thus far, and the continuous secretion of low levels of gastric acid into the stomach will promote the occurrence and development of atrophy and lead to an increase in the risk of development of GC [28].